Informações: Esta não é a versão mais recente do modelo de dados. Uma visão geral da versão pode ser encontrada à esquerda em Versões. Para a versão mais recente, clique aqui.
Informações:
Falhas:
ID
12386
Descrição
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5) Description of Form: Secondary Primary Malignancy Form
Palavras-chave
Versões (2)
- 11/11/2015 11/11/2015 -
- 18/12/2015 18/12/2015 -
Transferido a
11 de novembro de 2015
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Secondary Primary Malignancy Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Secondary Primary Malignancy Form
- StudyEvent: ODM
Similar models
Secondary Primary Malignancy Form
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
CL Item
Initial report (1)
C0684224 (UMLS CUI-1)
C0205435 (UMLS CUI-2)
C0205435 (UMLS CUI-2)
CL Item
Follow up report (2)
C1704685 (UMLS CUI-1)
CL Item
Final report (3)
C0460114 (UMLS CUI-1)
Date report
Item
date
C1302584 (UMLS CUI [1])
Date of birth
Item
date
C0421451 (UMLS CUI [1])
CL Item
acute leukemia* (1)
C0085669 (UMLS CUI-1)
CL Item
MDS* (2)
C3463824 (UMLS CUI-1)
CL Item
lymphoma* (3)
C0024299 (UMLS CUI-1)
CL Item
solid skin tumour* (4)
C0037286 (UMLS CUI-1)
CL Item
solid tumour (excl. skin)* (5)
C0280100 (UMLS CUI-1)
CL Item
other* (8)
C0205394 (UMLS CUI-1)
Specify
Item
*Specify
text
C1521902 (UMLS CUI [1])
Date of diagnosis
Item
Date of diagnosis
date
C2316983 (UMLS CUI [1,1])
C0751623 (UMLS CUI [1,2])
C1302659 (UMLS CUI [2])
C0751623 (UMLS CUI [1,2])
C1302659 (UMLS CUI [2])
Date clinical diagnosis
Item
date
C2316983 (UMLS CUI [1])
CL Item
before start protocol treatment (0)
C0040808 (UMLS CUI-1)
CL Item
induction cycle I (1)
C3179010 (UMLS CUI-1)
CL Item
induction cycle II (2)
C3179010 (UMLS CUI-1)
CL Item
post induction cycle III (3)
C3179010 (UMLS CUI-1)
CL Item
autoHSCT (4)
C0194037 (UMLS CUI-1)
CL Item
alloHSCT (5)
C1705576 (UMLS CUI-1)
CL Item
maintenance (1-6)* (11-16)
C0481504 (UMLS CUI-1)
CL Item
follow up (17)
C1522577 (UMLS CUI-1)
CL Item
other* (18)
C0205394 (UMLS CUI-1)
Cycle Number
Item
integer
C2045829 (UMLS CUI [1])
Specify
Item
text
C1521902 (UMLS CUI [1])
Pathology Result
Item
Pathology Result (Please send in copy of report if available)
text
C0807321 (UMLS CUI [1])
CL Item
Initial report (1)
C0684224 (UMLS CUI-1)
C0205435 (UMLS CUI-2)
C0205435 (UMLS CUI-2)
CL Item
Follow up report (2)
C1704685 (UMLS CUI-1)
CL Item
Final report (3)
C0460114 (UMLS CUI-1)
Date Report
Item
date
C1302584 (UMLS CUI [1])
CL Item
no (0)
C0445106 (UMLS CUI-1)
CL Item
chemotherapy only (1)
C3665472 (UMLS CUI-1)
CL Item
surgery (2)
C0543467 (UMLS CUI-1)
CL Item
radiotherapy (3)
C1522449 (UMLS CUI-1)
CL Item
monoclonal antibodies (4)
C0003250 (UMLS CUI-1)
CL Item
combination* (5)
C0009429 (UMLS CUI-1)
CL Item
other, please specify* (8)
C0205394 (UMLS CUI-1)
Specify
Item
*Specify
text
C1521902 (UMLS CUI [1])
Date of start treatment
Item
Date of start treatment
date
C0087111 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
CL Item
CR (1)
C0677874 (UMLS CUI-1)
CL Item
PR (2)
C1521726 (UMLS CUI-1)
CL Item
stable disease (3)
C0677946 (UMLS CUI-1)
CL Item
progressive disease (4)
C1335499 (UMLS CUI-1)
CL Item
other, please specify* (8)
C0205394 (UMLS CUI-1)
Specify
Item
*Specify
text
C1521902 (UMLS CUI [1])
Date response
Item
Date response achieved
date
C1704632 (UMLS CUI [1])
Date last contact
Item
date
C0805839 (UMLS CUI [1])
CL Item
alive (0)
CL Item
dead (1)
Item Group
External/environmental exposures (Please provide any information about external / environmental exposures that might be risk factors for the reported SPM. If no information is available, fill out as ‘unknown’.)
C2220266 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
Specify
Item
*Specify
text
C1521902 (UMLS CUI [1])
CL Item
Initial report (1)
C0684224 (UMLS CUI-1)
C0205435 (UMLS CUI-2)
C0205435 (UMLS CUI-2)
CL Item
Follow up report (2)
C1704685 (UMLS CUI-1)
CL Item
Final report (3)
C0460114 (UMLS CUI-1)
Date report
Item
date
C1302584 (UMLS CUI [1])
Item Group
Relevants Family's History (please provide relevant family’s medical history (such as known genetic mutations for breast cancer, prostate cancer, etc. or family member(s) – such as parents siblings, etc – with the same malignancy). Fill out ‘none’ if there is no relevant family medical history, or fill out ‘unknown’ if information is not available)
C0241889 (UMLS CUI-1)
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
unknown (9)
C0439673 (UMLS CUI-1)
Specify
Item
*Specify
text
C1521902 (UMLS CUI [1])
Comments
Item
text
C0947611 (UMLS CUI [1])